Sarepta Therapeuticals shares down 5% after company misses Q1 expectations
Sarepta Therapeutics Inc. shares fell nearly 5% late Thursday after the biopharma company reported a wider-than-expected adjusted first-quarter loss and sales also missed targets. Sarepta said it lost $35.4 million, or 55 cents a share, in the quarter, versus earnings of $84.1 million, or $1.50 a share, in the year-ago period. Adjusted for one-time items, Sarepta lost $17.9 million, or 28 cents a share, compared with a net loss of $31.4 million, or 57 cents a share, a year ago. Sales rose to $64.6 million in the quarter... Читать дальше...